The efficacy and safety of milnacipran 50 mg bid in patients with major depression: the results of a clinical trial

Basit Öğe Kaydı
dc.contributor.authorGogus, A.
dc.contributor.authorOral, T.
dc.contributor.authorBerksun, O.
dc.contributor.authorKaramustafalioglu, O.
dc.contributor.authorVahip, S.
dc.contributor.authorTunca, Z.
dc.contributor.authorYazici, O.
dc.date.accessioned2019-10-27T20:49:33Z
dc.date.available2019-10-27T20:49:33Z
dc.date.issued2009
dc.departmentEge Üniversitesien_US
dc.description22nd Congress of the European-College-of-Neuropsychopharmacology -- SEP 12-16, 2009 -- Istanbul, TURKEYen_US
dc.description.sponsorshipEuropean Coll Neuropsychopharmacolen_US
dc.identifier.doi10.1016/S0924-977X(09)70586-3
dc.identifier.endpageS382en_US
dc.identifier.issn0924-977X
dc.identifier.startpageS381en_US
dc.identifier.urihttps://doi.org/10.1016/S0924-977X(09)70586-3
dc.identifier.urihttps://hdl.handle.net/11454/42887
dc.identifier.volume19en_US
dc.identifier.wosWOS:000270312500401en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofEuropean Neuropsychopharmacologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe efficacy and safety of milnacipran 50 mg bid in patients with major depression: the results of a clinical trialen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu